131 related articles for article (PubMed ID: 20368235)
1. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease.
Rutter MK; Nesto RW
Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235
[TBL] [Abstract][Full Text] [Related]
2. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
Sobel BE
Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
[TBL] [Abstract][Full Text] [Related]
3. [The BARI 2D study].
Mafrici A; Briguori C
G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
[No Abstract] [Full Text] [Related]
4. A randomized trial of therapies for type 2 diabetes and coronary artery disease.
; Frye RL; August P; Brooks MM; Hardison RM; Kelsey SF; MacGregor JM; Orchard TJ; Chaitman BR; Genuth SM; Goldberg SH; Hlatky MA; Jones TL; Molitch ME; Nesto RW; Sako EY; Sobel BE
N Engl J Med; 2009 Jun; 360(24):2503-15. PubMed ID: 19502645
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
6. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2014 Apr; 129(16):e460-1. PubMed ID: 24753557
[No Abstract] [Full Text] [Related]
7. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
Khan AA; Chung MJ; Novak E; Brown DL
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
[TBL] [Abstract][Full Text] [Related]
8. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
[TBL] [Abstract][Full Text] [Related]
9. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
[TBL] [Abstract][Full Text] [Related]
11. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Magee MF; Isley WL;
Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Barsness GW; Gersh BJ; Brooks MM; Frye RL;
Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group
Am Heart J; 2008 Sep; 156(3):528-536, 536.e1-5. PubMed ID: 18760137
[TBL] [Abstract][Full Text] [Related]
14. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
Kuller LH
Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
[TBL] [Abstract][Full Text] [Related]
16. Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).
Pop-Busui R; Lombardero M; Lavis V; Forker A; Green J; Korytkowski M; Sobel BE; Jones TL;
Am J Cardiol; 2009 Jul; 104(1):52-8. PubMed ID: 19576321
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
18. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
[TBL] [Abstract][Full Text] [Related]
19. The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).
Chung SC; Hlatky MA; Faxon D; Ramanathan K; Adler D; Mooradian A; Rihal C; Stone RA; Bromberger JT; Kelsey SF; Brooks MM;
J Am Coll Cardiol; 2011 Aug; 58(8):810-9. PubMed ID: 21835316
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
Hlatky MA; Melsop KA; Boothroyd DB;
Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
